Vertex Signs Multispecific T-Cell Engager Collaboration with AbCellera for Autoimmune Diseases
By Nikita Negi
Pharma Deals Review: Vol 2026 Issue 8 (Table of Contents)
Published: 7 Aug-2026
DOI: 10.3833/pdr.v2026.i8.3032 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In an effort to strengthen its immunology pipeline and expand its presence in autoimmune diseases, Vertex Pharmaceuticals has entered into a collaboration agreement with AbCellera Biologics to discover and develop multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS